Allergic Rhinitis: Intranasal Corticosteroids or Oral Antihistamines

Identifying Attributes

Care Settings
Primary Care
Country
United States of America
Publishing Organisation
Centers for Medicare & Medicaid Services (CMS): Traditional Merit-Based Incentive Payment System (MIPS) Qualified Clinical Data Registry Measures for Primary Care
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Domain
Medications and Medication Management

Defining Attributes

Definition

Percentage of patients aged 2 years and older with a diagnosis of allergic rhinitis who are prescribed or recommended intranasal corticosteroids (INS) or non-sedating oral antihistamines

Numerator

Patients who are prescribed or recommended intranasal steroids (INS) or non-sedating oral antihistamines. A prescription for or medication reconciliation of over-the-counter medications can be used to identify patients taking medications

Denominator

All patients aged 2 years and older with a diagnosis of allergic rhinitis

Exclusions

Patients with an allergy to oral antihistamines or intranasal corticosteroids. Patients with prostate cancer or benign prostatic hypertrophy as these patients may be intolerant of medications. Patients with a history of epistaxis due to intranasal steroid use. Patients with glaucoma. Patient refusal.

Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

Data Attributes

Type of Data Collection
Standardised clinical data
Data Collection Methods

American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Reg-entSM Registry

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
23 July 2025